SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-08-001553
Filing Date
2008-04-08
Accepted
2008-04-08 17:03:29
Documents
3
Period of Report
2008-04-02
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 17423
2 PRESS RELEASE DATED APRIL 8, 2008 exhibit99-1.htm EX-99.1 5669
3 exhibit99-1x1x1.jpg GRAPHIC 4010
  Complete submission text file 0001062993-08-001553.txt   30699
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Filer) CIK: 0000891504 (see all company filings)

IRS No.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-33227 | Film No.: 08745831
SIC: 2833 Medicinal Chemicals & Botanical Products